Ritonavir & Lopinavir

Form: Tablet and Oral Solution

Strength: Tab: Lopinavir 200 mg + Ritonavir 50 mg; oral solution:80 mg / 20 mg per mL

Reference Brands: Kaletra(US & EU)

Category: Anti Viral

Lopinavir & Ritonavir Tablets, widely marketed as Kaletra®, are a fixed-dose combination of two protease inhibitors used in the treatment of HIV-1 infection. Each tablet typically contains Lopinavir 200 mg and Ritonavir 50 mg, with Ritonavir boosting the effectiveness of Lopinavir. This antiretroviral combination remains vital in HIV care, especially in resource-limited settings and global treatment programs. PharmaB2B platforms connect global buyers, NGOs, and procurement agencies with WHO-GMP and USFDA-approved manufacturers offering bulk supply at competitive rates. Ideal for tenders and institutional supply, this therapy supports consistent, affordable access to HIV medications worldwide.